US equities |
MU $1,088.00 ▲+4.06% NVDA $237.47 ▼-0.74% SNDK $1,692.42 ▲+1.92% SPCX $167.60 ▼-2.51% AMD $645.86 ▼-0.55% AAPL $336.67 ▲+0.91% TSLA $377.81 ▼-0.75% META $721.31 ▼-2.38%
FinancialContent

Latest News about Nanomerics

Recent news which mentions Nanomerics

Virpax Pharmaceuticals 2022 R&D Expenses Grow 122% To $10.8M, Here Are The Details
Tickers VRPX
Tags premium Market News News
From Benzinga
Virpax Completes FDA Required Preclinical Toxicology Studies For Its Licensed Molecular Envelope Technology
Tickers VRPX
Tags Sheila A/ Mathias Markets Benzinga
From Benzinga
Virpax Receives pre-IND Application Guidance From The FDA For Its CBD-Based Drug Candidate For Epilepsy
Tickers VRPX
Tags Sheila A/ Mathias Markets Benzinga
From Benzinga